Name: IFIGENEIA Kickoff Meeting - Aristotle University of Thessaloniki, Greece, 3-4 April 2025
Start: 2025-04-03T00:00:00+03:00
End: 2025-04-04T20:00:00+03:00
Location: No location set

Thursday 3 April
- Thu 3 Apr
- Fri 4 Apr
- 1
  
  Registration
- 2
  
  Welcome to IFIGENEIA
- Introduction per Partner
  
  All Partners
  - 3
    
    Greek Hub
    
    AUTH - RCM - BIOKOSMOS - AMTH - CERTH - GNP - TPOLIS - NCSRD - YFOS
    
    partners profile_YFOS.PDF
  - 4
    
    Slovenian Hub
    
    UL - IJS - COSYLAB - SIH - IAS
  - 5
    
    Cypriot Hub
    
    TALOS - UCY - PASYKAF - SHSO
    
    IFIGENEIA-Partners Profile-PASYKAF.pdf
    
    IFIGENEIA-Partners Profile-RTD TALOS v01.pdf
  - 6
    
    Bosnian Hub
    
    UNSA
  - 7
    
    Collaborators
    
    CERN - DKFZ - GSI
- 11:20
  
  Coffee Break
- 8
  
  Presentation from Project Officer + (Q&A)
  
  Speaker: Raquel FERNANDEZ HORCAJADA (EU)
  
  PO_IFIGENEIA_KoM_Excellence Hubs.pdf
- 9
  
  Particle accelerators for societal applications
  
  Alessandra Lombardi (CERN)
- 10
  
  Invited talk on Radiopharmaceutical
  
  Joao Seco (DKFZ)
- 13:15
  
  Lunch Break
- WP3: LINAC design dedicated to radioisotope production and other societal applications
  
  AUTH-CERN-NCSRD-AMTH-YFOS- COSYLAB- IJS
  - 11
    
    T3.1 LINAC/RFQ design and beam dynamics studies
    
    AUTH - CERN
  - 12
    
    T3.2 Beam parameters and hardware specifications for different operational scenarios
    
    CERN
  - 13
    
    T3.3 Targets’ optimization and handling for different isotope production scenarios
    
    AUTH - CERN
  - 14
    
    T3.4 Control system development project plan
    
    COSYLAB
  - 15
    
    T3.5 Study of the Safety and Radiation protection requirements
    
    NCSRD
  - 16
    
    T3.6 Development of Computational tools
    
    AUTH
- 15:30
  
  Coffee Break
- WP4: Radioisotope production and radiopharmaceuticals
  
  UL
  - 17
    
    T4.1 Develop Lab conditions (radiation protection) needed for producing these isotopes.
    
    BIOKOSMOS
  - 18
    
    T4.2 Identify best Isotopes for production with LINAC
    
    UL
  - 19
    
    T4.3 Investigate best Ligands for development within excellent hub
    
    UL - DKFZ
  - 20
    
    T4.4 Perform the development and testing of ligand-isotope compound
    
    DKFZ
  - 21
    
    T4.5 Develop protocols for pre-clinical evaluation of ligand-isotope compound
    
    GNP
- WP6: Mentorship
  
  UCY
  - 22
    
    T6.1 Accelerator School
    
    UCY
  - 23
    
    T6.2 Master Classes in Particle Therapy
    
    GSI
  - 24
    
    T6.3 Implementation of a Virtual Interactive RadioIsotope production unit
    
    CERTH
    
    IFIGENEIA_T6.3_template_v01.pdf
Friday 4 April
- Thu 3 Apr
- Fri 4 Apr
- WP5:Business plan for end users: From science to business including spinoffs
  
  IFIGENEIA-WP5 v01.pdf
  - 25
    
    T5.1 Management of Key Exploitable Results (KERs)
    
    TALOS
    
    IFIGENEIA T5-1 v01.pdf
  - 26
    
    T5.2 Development of Business Plan(s) for Seeking Financing beyond the Project
    
    TALOS
    
    IFIGENEIA T5-2 v01.pdf
  - 27
    
    T5.3 Basic Sustainability for the Excellence Hubs
    
    RCM
    
    IFIGENEIA T5-3 v01.pdf
- WP2: Education, Dissemination, Inclusion and Diversity
  
  IJS
  - 28
    
    T2.1 Communication and dissemination activities and planning
    
    IJS
  - 29
    
    T2.2 Skills training and Trainers’ training
    
    TPOLIS
  - 30
    
    T2.3 Secondments and good practices exchange
    
    GNP
  - 31
    
    T2.4 Inclusion strategies and activities
    
    AUTH
- 10:50
  
  Coffee Break
- WP1: Project Management
  
  AUTH
  - 32
    
    T1.1 Project coordination & financial management
    
    AUTH
  - 33
    
    T1.2 Quality assurance, risks, ethics and IPR management
    
    COSYLAB
  - 34
    
    T1.3 Scientific, innovation & technical management
    
    AUTH
  - 35
    
    T1.4 Capacity Building
    
    CY
  - 36
    
    T1.5 Data management
    
    SHSO
- 37
  
  Action points & Discussion
  
  AUTH / All Partners
- 38
  
  Next meeting arrangements and meeting closure
  
  AUTH / All Partners